{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:04:36Z","timestamp":1778677476105,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.mehy.2004.04.012","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T14:54:10Z","timestamp":1090594450000},"page":"1047-1050","source":"Crossref","is-referenced-by-count":13,"title":["Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment"],"prefix":"10.1016","volume":"63","author":[{"given":"Shih-Jen","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.04.012_BIB1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2004.04.012_BIB2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.2878495","article-title":"Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics","volume":"234","author":"Wong","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.mehy.2004.04.012_BIB3","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mehy.2004.04.012_BIB4","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","article-title":"Elevated dopa decarboxylase activity in living brain of patients with psychosis","volume":"91","author":"Reith","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mehy.2004.04.012_BIB5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am. J. Psychiat"},{"key":"10.1016\/j.mehy.2004.04.012_BIB6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1976.01770040061011","article-title":"Potentiation by metyrosine of thioridazine effects in chronic schizophrenics A long-term trial using double-blind crossover technique","volume":"33","author":"Walinder","year":"1976","journal-title":"Arch. Gen. Psychiat"},{"key":"10.1016\/j.mehy.2004.04.012_BIB7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1176\/ajp.135.4.488","article-title":"Addition of reserpine to antipsychotic medication in refractory chronic schizophrenic outpatients","volume":"135","author":"Bacher","year":"1978","journal-title":"Am. J. Psychiat"},{"key":"10.1016\/j.mehy.2004.04.012_BIB8","first-page":"1","article-title":"Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process","volume":"22","author":"Law","year":"1982","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.mehy.2004.04.012_BIB9","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.1016\/S0021-9258(19)84774-9","article-title":"Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level","volume":"264","author":"Bouvier","year":"1989","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mehy.2004.04.012_BIB10","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1074\/jbc.273.12.6976","article-title":"Role of clathrin-mediated endocytosis in agonist-induced down-regulation of the beta2-adrenergic receptor","volume":"273","author":"Gagnon","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mehy.2004.04.012_BIB11","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.86.13.4853","article-title":"cAMP stimulates transcription of the beta2-adrenergic receptor gene in response to short-term agonist exposure","volume":"86","author":"Collins","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mehy.2004.04.012_BIB12","doi-asserted-by":"crossref","first-page":"11471","DOI":"10.1074\/jbc.272.17.11471","article-title":"A 20-nucleotide (A+U)-rich element of beta2-adrenergic receptor (beta2AR) mRNA mediates binding to beta2AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA","volume":"272","author":"Tholanikunnel","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mehy.2004.04.012_BIB13","first-page":"878","article-title":"The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells","volume":"45","author":"Zhang","year":"1994","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.mehy.2004.04.012_BIB14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0306-4522(93)90238-B","article-title":"Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum","volume":"54","author":"Chen","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2004.04.012_BIB15","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/0024-3205(84)90309-6","article-title":"In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-dopa","volume":"34","author":"Ponzio","year":"1985","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2004.04.012_BIB16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1126\/science.347574","article-title":"Schizophrenic symptoms improve with apomorphine","volume":"200","author":"Tamminga","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.mehy.2004.04.012_BIB17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-003-1672-y","article-title":"A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications","volume":"171","author":"Jaskiw","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.mehy.2004.04.012_BIB18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0169-328X(98)00009-6","article-title":"Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary","volume":"55","author":"Inoue","year":"1998","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.mehy.2004.04.012_BIB19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1254\/jjp.86.376","article-title":"Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy","volume":"86","author":"Inoue","year":"2001","journal-title":"Jpn. J. Pharmacol"},{"key":"10.1016\/j.mehy.2004.04.012_BIB20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568007024606195","article-title":"Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis","volume":"1","author":"Tamminga","year":"2002","journal-title":"Curr. Drug Target CNS Neurol. Disord"},{"key":"10.1016\/j.mehy.2004.04.012_BIB21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2004.04.012_BIB22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0165-6147(97)01091-2","article-title":"Endocytosis and recycling of G protein-coupled receptors","volume":"18","author":"Koenig","year":"1997","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.mehy.2004.04.012_BIB23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0165-6147(00)01620-5","article-title":"Role of endocytosis in mediating downregulation of G-protein-coupled receptors","volume":"22","author":"Tsao","year":"2001","journal-title":"Trends Pharmacol. Sci"},{"issue":"Suppl 4","key":"10.1016\/j.mehy.2004.04.012_BIB24","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"J. Clin. Psychiat"},{"key":"10.1016\/j.mehy.2004.04.012_BIB25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/070674370304801116","article-title":"Aripiprazole-induced improvement in tardive dyskinesia","volume":"48","author":"Duggal","year":"2003","journal-title":"Can. J. Psychiat"},{"key":"10.1016\/j.mehy.2004.04.012_BIB26","first-page":"560","article-title":"Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells","volume":"49","author":"Itokawa","year":"1996","journal-title":"Mol. Pharmacol"},{"key":"10.1016\/j.mehy.2004.04.012_BIB27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(94)91581-4","article-title":"Association of dopamine D2 receptor molecular variant with schizophrenia","volume":"343","author":"Arinami","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.04.012_BIB28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0306-4522(98)00653-8","article-title":"Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo","volume":"91","author":"Willins","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2004.04.012_BIB29","doi-asserted-by":"crossref","first-page":"28900","DOI":"10.1074\/jbc.274.41.28900","article-title":"Beta(2)-adrenergic receptor down-regulation evidence for a pathway that does not require endocytosis","volume":"274","author":"Jockers","year":"1999","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.mehy.2004.04.012_BIB30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(96)00920-X","article-title":"Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum","volume":"321","author":"Inoue","year":"1997","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.mehy.2004.04.012_BIB31","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1210\/endo-114-6-2344","article-title":"Down-regulation by 17 beta-estradiol of D2 dopamine receptors in the MtTF4 pituitary tumor","volume":"114","author":"Albaladejo","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2004.04.012_BIB32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01256469","article-title":"Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005","volume":"64","author":"Nowak","year":"1985","journal-title":"J. Neural. Trans"},{"key":"10.1016\/j.mehy.2004.04.012_BIB33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<275::AID-SYN5>3.0.CO;2-8","article-title":"Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors","volume":"30","author":"Izenwasser","year":"1998","journal-title":"Synapse"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704003056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704003056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:07:53Z","timestamp":1734484073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704003056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0306987704003056"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.04.012","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}